Table 4 Antibody positivity (prevalence) comparison by immunocompromised clinical variables.
From: Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study
Antibody | Active immunotherapy | Steroid medication | Leukopenia | Lymphopenia | Neutropenia |
|---|---|---|---|---|---|
WT (Cho cells) | 0.063 | 0.530 | 0.147 | 0.001 | 0.925 |
WT (Hek cells) | 0.043 | 0.737 | 0.195 | 0.004 | 0.435 |
Alpha | 0.167 | 1.000 | 0.249 | 0.018 | 0.171 |
Beta | 0.006 | 0.225 | 0.011 | 0.000 | 0.111 |
Gamma | 0.013 | 0.230 | 0.071 | 0.054 | 0.064 |
Delta | 0.006 | 0.151 | 0.024 | < 0.001 | 0.280 |
Omicron | 0.001 | 0.174 | 0.066 | 0.791 | 0.020 |
NCapsid | 0.152 | 1.000 | 0.363 | 1.000 | 0.680 |
